TORONTO, Sept. 23, 2021 /CNW/ – Wake Network, Inc. (“Wake” or the “Company“), a global leader in naturally-derived psilocybin production and the developer of genomics-based integration therapies, is pleased to announce the Company has received a Certificate of Drug Registration from the Jamaican Ministry of Health & Wellness for its naturally derived psilocybin microdose formulation, PSIL428.
